Two major growth drivers for the market include the rising prevalence of chronic diseases requiring regular blood transfusions, such as cancer and blood disorders, and the increasing number of surgical procedures being performed. Additionally, the growing aging population in the U.S. is also expected to contribute to the demand for blood and blood components.
In terms of segment analysis, the market can be divided into whole blood, red blood cells, platelets, plasma, and other blood components. Red blood cells are expected to dominate the market, given their crucial role in oxygen transport and the high demand for blood transfusions in surgical procedures and patients with anemia.
The competitive landscape of the U.S. blood and blood components market is characterized by the presence of several key players, including American Red Cross, Vitalant, New York Blood Center, and the Blood Centers of America. These companies are focusing on expanding their network of blood donation centers, implementing advanced technologies for blood collection and processing, and collaborating with healthcare providers to meet the increasing demand for blood and blood components in the U.S.